Marko Kutleša

Marko Kutleša

Auto-generated profile, based on publicly available information

Marko Kutleša

Department of Intensive Care Medicine and Neuroinfectology, University Hospital for Infectious Diseases “Dr. Fran Mihaljević”, 10000 Zagreb, Croatia

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
HPHana Panic
Hana Panic
BGBranimir Gjurasin
Branimir Gjurasin
MSMarija Santini
Marija Santini
MKMarko Kutlesa
Marko Kutlesa
NPNeven Papić
Neven Papić
Healthcare associated meningitis and ventriculitis (HCAMV) are serious complications of neurosurgical procedures. We conducted a retrospective cohort study of patients with HCAMV treated at the University Hospital for Infectious Diseases Zagreb during the 2013–2019 period. A total of 144 patients with 151 episodes of HCAMV were included. The most common indications for neurosurgical procedures were brain tumor, hemorrhage and hydrocephalus. Etiology was identified in 90 (59.6%) episodes (either positive CSF culture or positive PCR), and in other 61 (40.39%) the diagnosis of HCAMV was made based on clinical and CSF parameters, without microbiologic confirmation. Carbapenem-resistant Acinetobacter baumannii was the most common pathogen (15.89%), followed by Staphylococcus aureus (13.91%), Pseudomonas aeruginosa (13.25%) and Coagulase negative staphylococci (7.95%). Overall, 24 (16.3%) patients died, and the majority had adverse outcomes, persistent vegetative state (8, 5.56%) and severe disability (31, 21.53%). The worst clinical outcomes were observed in A. baumannii infections. High rate of complications, the need for external ventricular drainage (re)placement often complicated with nosocomial infections and prolonged stay in intensive care units were observed. Clinicians should be aware of local microbial epidemiology on guiding proper empirical antimicrobial treatment in patients with HCAMV.

1 April 2017 in Minerva Anestesiologica
Verified
Journal Article
Closed access
MKMarko Kutleša
Marko Kutleša
MSMarija Santini
Marija Santini
VKVladimir Krajinović
Vladimir Krajinović
NPNeven Papić
Neven Papić
ANAnđa Novokmet
Anđa Novokmet
BBBruno Baršić
Bruno Baršić
Article: Nosocomial blood stream infections in patients treated with venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome - Minerva Anestesiologica 2017 May;83(5):493-501 - Minerva Medica - Journals

1 July 2012 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
MKMarko Kutleša
Marko Kutleša
EMEmilija Mlinarić-Missoni
Emilija Mlinarić-Missoni
LHLóránt Hatvani
Lóránt Hatvani
DVDarko Voncina
Darko Voncina
SSSilvio Simon
Silvio Simon
BBBruno Baršić
Bruno Baršić

1 August 2014 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
MKMarko Kutleša
Marko Kutleša
DLDragan Lepur
Dragan Lepur
BBBruno Baršić
Bruno Baršić

23 December 2022 in Life
Verified
Journal Article
Open access
PDF file
BGBranimir Gjurasin
Branimir Gjurasin
MJMia Jeličić
Mia Jeličić
MKMarko Kutleša
Marko Kutleša
NPNeven Papić
Neven Papić
Community-acquired pneumonia (CAP) is one of the leading causes of morbidity and mortality, while nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. NAFLD is associated with systemic changes in immune response, possibly linked to CAP severity. However, the impact of NAFLD on CAP outcomes has not been determined. The aim of this study was to evaluate clinical course, complications and outcomes of severe CAP requiring ICU treatment in patients with NAFLD in the pre-COVID-19 era. A retrospective cohort study included 138 consecutively hospitalized adult patients with severe CAP admitted to the ICU during a 4-year period: 80 patients with NAFLD and 58 controls. Patients with NAFLD more frequently presented with ARDS (68.7% vs. 43.1%), and required invasive mechanical ventilation (86.2% vs. 63.8%), respiratory ECMO (50% vs. 24.1%), and continuous renal replacement therapy (62.5% vs. 29.3%). Mortality was significantly higher in the NAFLD group (50% vs. 20.7%), and the time from hospital admission to death was significantly shorter. In survival analysis, NAFLD (HR 2.21, 95%CI 1.03–5.06) was associated with mortality independently of other components of metabolic syndrome. In conclusion, our study identified NAFLD as an independent predictor of mortality in patients with severe CAP.

14 October 2014 in The International Journal of Artificial Organs
Verified
Journal Article
Closed access
MKMarko Kutleša
Marko Kutleša
ANAnđa Novokmet
Anđa Novokmet
RMRenata Josipović Mraović
Renata Josipović Mraović
BFBoris Filar
Boris Filar
PMPetar Mardešić
Petar Mardešić
BBBruno Baršić
Bruno Baršić
Introduction: Extracorporeal membrane oxygenation (ECMO) has been effective in the treatment of H1N1-induced ARDS across the globe. However, the evidence supporting the use of ECMO in ARDS is still being collected. The intention of this study was to add a piece of puzzle to the growing body of evidence on the use of ECMO in ARDS patients. Methods: The study included adult patients with H1N1-induced ARDS treated with ECMO at the University Hospital for Infectious Diseases in Zagreb, Croatia between October 2009 and December 2013. Results: 17 patients with H1N1-induced ARDS treated with ECMO were included in the study. The patient cohort of the study was young with a median age of 43 years (range 23–74). The hospital mortality was 35%. Possible variables associated with mortality were analyzed and only hemolysis was found to be significant. Conclusions: Our results confirm the usefulness of ECMO treatment in patients with H1N1-induced ARDS.